Page 192 - product-manual
P. 192

TM/MC  TM/MC
                                          PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





            Niacinamide [Vitamin B ] (C H N O)
                                        3    6  6  2

            Dogs and cats derive most of their energy from oxidation-reduction (redox) reactions, which
            are processes involving the transfer of electrons. As many as 200 enzymes require the niacin
            coenzymes, nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide
            phosphate (NADP), mainly to accept or donate electrons for redox reactions. NAD functions
            most  often  in  energy  producing  reactions  involving  the  catabolism  of  carbohydrates,  fats,
            proteins, and alcohol. NADP functions more often in anabolic reactions, such as in the synthesis
            of all macromolecules, including fatty acids and cholesterol (Brody, 1999).

            A vitamin B deficiency is characterized by loss of appetite, fatigue, apathy and mouth ulcers,
                      3
            diarrhoea,  emaciation  and  pruritic  dermatitis  of  the  hind  legs  and  ventral  abdomen.  Cats
            need  more  niacin  than  dogs.  Dogs  are  able  to  synthesize  nicotinamide  endogenously  from
            tryptophan; cats do not produce any measurable quantities. Cats possess all the enzymes of the
            pathway of niacin synthesis, but the activity of picolinic carboxylase is extremely high, precluding
            any measurable synthesis of nicotinic acid (NRC, 2006; Ettinger & Feldman, 2000a).




                TOXICOLOGY  Toxicity for vitamin B  has not been documented in dogs and cats when administered orally in therapeutic doses.
                                       3
                    However, it has been reported that repeated oral administration of 2 g/day of nicotinic acid produced bloody
                    feces, convulsions and death in a few dogs (Chen et al., 1938). Oral LD  of niacinamide is 4.5-7 g/kg of body
                                                                                 50
                    weight in rats (NRC, 1987).




                           DRUG     Validated  interactions  studies  do  not  exist  for  niacinamide  preparations.  However,
                  INTERACTIONS      niacinamide inhibits metabolism of primidone in mice and metabolism of primidone and
                                    carbamazepine  in  humans.  This  probably  occurs  by  inhibition  of  cytochrome  P-450  by
                                    nicinamide (Bourgeois et al., 1982).





























                                                                                                 VimForte -VM TM       |  7
   187   188   189   190   191   192   193   194   195   196   197